NSE - Free Realtime Quote • INR
Granules India Limited (GRANULES.NS)
As of 12:35 PM GMT+5:30. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Krishna Prasad Chigurupati B.Sc. | Chairman & MD | 353.56M | -- | 1954 |
| Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. | Joint MD, CEO & Additional Director | 94.56M | -- | 1963 |
| Mr. Harsha Chigurupati | Executive Director | 35.36M | -- | 1983 |
| Mr. Sanjay Kumar | President, Chief Strategy & Sustainability Officer | -- | -- | -- |
| Mr. Mukesh Surana | Chief Financial Officer | -- | -- | 1981 |
| Mr. Sethu Madhavan Sankaran | Senior Vice President of API Manufacturing & Operations | -- | -- | -- |
| Dr. P. V. Srinivas | Chief Technology Officer | -- | -- | 1966 |
| Ms. Chaitanya Tummala | Company Secretary & Compliance Officer | 7.89M | -- | -- |
| Mr. Atul Dhavle B.E. | Chief Human Resources Officer | -- | -- | 1970 |
| Ms. Priyanka Chigurupati | Whole-Time Director | 9.65M | -- | -- |
Granules India Limited
My Home Hub
2nd Floor 3rd Block Madhapur
Hyderabad, 500081
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 3,650
Description
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
Corporate Governance
Granules India Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Aug 03, 2023Ex-Dividend Date
Upcoming Events
May 14, 2024 - May 18, 2024
Granules India Limited Earnings Call
Related Tickers
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,029.95
-0.90%
LUPIN.NS Lupin Limited
1,595.00
-0.54%
LAURUSLABS.NS Laurus Labs Limited
432.75
+0.63%
AUROPHARMA.NS Aurobindo Pharma Limited
1,085.45
+0.85%
IPCALAB.NS Ipca Laboratories Limited
1,314.10
-1.12%
SUNPHARMA.NS Sun Pharmaceutical Industries Limited
1,493.20
-3.05%
DIVISLAB.NS Divi's Laboratories Limited
3,743.15
+0.15%
FDC.NS FDC Limited
445.50
-1.12%
MANKIND.NS Mankind Pharma Limited
2,399.95
+2.54%
STAR.NS Strides Pharma Science Limited
879.95
+4.31%